294 related articles for article (PubMed ID: 1713692)
41. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
Healey D; Dianda L; Moore JP; McDougal JS; Moore MJ; Estess P; Buck D; Kwong PD; Beverley PC; Sattentau QJ
J Exp Med; 1990 Oct; 172(4):1233-42. PubMed ID: 1698911
[TBL] [Abstract][Full Text] [Related]
42. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site.
Camerini D; Seed B
Cell; 1990 Mar; 60(5):747-54. PubMed ID: 2107024
[TBL] [Abstract][Full Text] [Related]
43. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
44. Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer.
Capobianchi MR; Ankel H; Ameglio F; Paganelli R; Pizzoli PM; Dianzani F
AIDS Res Hum Retroviruses; 1992 May; 8(5):575-9. PubMed ID: 1381203
[TBL] [Abstract][Full Text] [Related]
45. Use of human CD4 transgenic mice for studying immunogenicity of HIV-1 envelope protein gp120.
Seagal J; Spectorman E; Gershoni JM; Denisova GF
Transgenic Res; 2001 Apr; 10(2):113-20. PubMed ID: 11305358
[TBL] [Abstract][Full Text] [Related]
46. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
47. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
Wang JH; Meijers R; Xiong Y; Liu JH; Sakihama T; Zhang R; Joachimiak A; Reinherz EL
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10799-804. PubMed ID: 11535811
[TBL] [Abstract][Full Text] [Related]
48. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2001 Nov; 75(22):11096-105. PubMed ID: 11602749
[TBL] [Abstract][Full Text] [Related]
49. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.
Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA
Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526
[TBL] [Abstract][Full Text] [Related]
50. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
[TBL] [Abstract][Full Text] [Related]
51. Human CD4 binds immunoglobulins.
Lenert P; Kroon D; Spiegelberg H; Golub ES; Zanetti M
Science; 1990 Jun; 248(4963):1639-43. PubMed ID: 2363051
[TBL] [Abstract][Full Text] [Related]
52. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
53. An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques.
Schwartz JA; Prado I; Misamore J; Weiss D; Francis J; Pal R; Huaman M; Cristillo A; Lewis GK; Gallo RC; DeVico AL; Fouts TR
Clin Vaccine Immunol; 2016 Jul; 23(7):618-27. PubMed ID: 27193040
[TBL] [Abstract][Full Text] [Related]
54. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
55. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding.
Choe HR; Sodroski J
J Acquir Immune Defic Syndr (1988); 1992; 5(2):204-10. PubMed ID: 1732513
[TBL] [Abstract][Full Text] [Related]
56. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
Ho DD; Fung MS; Cao YZ; Li XL; Sun C; Chang TW; Sun NC
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8949-52. PubMed ID: 1717992
[TBL] [Abstract][Full Text] [Related]
57. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion.
Pollard SR; Meier W; Chow P; Rosa JJ; Wiley DC
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11320-4. PubMed ID: 1763044
[TBL] [Abstract][Full Text] [Related]
58. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.
Kolchinsky P; Kiprilov E; Bartley P; Rubinstein R; Sodroski J
J Virol; 2001 Apr; 75(7):3435-43. PubMed ID: 11238869
[TBL] [Abstract][Full Text] [Related]
59. Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.
Moir S; Perreault J; Poulin L
J Virol; 1996 Nov; 70(11):8019-28. PubMed ID: 8892926
[TBL] [Abstract][Full Text] [Related]
60. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex.
Gershoni JM; Denisova G; Raviv D; Smorodinsky NI; Buyaner D
FASEB J; 1993 Sep; 7(12):1185-7. PubMed ID: 7690724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
